By analysing 803 individual patent families, CPA Global’s Analytics team used IP and patents to analyse the human gene therapy (HGT) sector to answer where gene therapy is in its evolution towards commercialisation and what key players and technologies are trending.
This Technology Intelligence Study, composed by our global team of analytics experts, uncovers detailed information and commercial content available via patent analysis.
- The spread of patent activity across major technologies favour a strong preference towards disease
- Gene therapy patent protection is strongly tied to clinical and therapeutic applications with 90% of patents in the past 20 years mentioning a specific target treatment
- Low patent volumes and the lack of commercial application proves the field is still immature and provides a very strong opportunity for new entrants to expand their technical footprint
- and more